US Patent Issued to TYK MEDICINES on Feb. 10 for "Compound used as RET kinase inhibitor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,681, issued on Feb. 10, was assigned to TYK MEDICINES INC. (Zhejiang, China).

"Compound used as RET kinase inhibitor and application thereof" was invented by Jun Li (Huzhou, China), Maolin Zheng (Huzhou, China), Chengshan Niu (Huzhou, China), Apeng Liang (Huzhou, China) and Yusheng Wu (Huzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of medicines. Specifically disclosed is a compound as represented by formula I', or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, symbols therein being as defined in the claims. The compound of the present invention may be ...